http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101683346-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2001a685e3ca018cedd7350df60fa614
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2008-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6698be23f5fec10d530151e97ac149e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84fa218e053c6b0892e3c3cf68716a80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47d79a92f4f9aafe241d6be9be63ca0a
publicationDate 2015-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-101683346-B
titleOfInvention Tirapazamine parenteral hydrous preparation and preparation method thereof
abstract The invention provides a Tirapazamine parenteral hydrous preparation and a preparation method thereof. The preparation comprises a buffer solution of organic acid salts except for citrates and lactates, or a buffer solution of inorganic acid salts, or a buffer solution composed of inorganic acid salts and organic acids, and Tirapazamine or available salts thereof, wherein the concentration of the buffer solution is 1-500 mmol/l, and the buffer solution is acceptable in medical preparations; the concentration of the Tirapazamine or available salts thereof is 0.01-4 mmol/l; and the pH value of the preparation is 2.0-7.0. The invention solves the problem of easy precipitation when the solution of Tirapazamine is put still in the prior art, enhances the stability and the safety of the preparation and meets the clinical and broad patients' requirements for the preparation.
priorityDate 2008-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005082867-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6153610-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447598823
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419712688
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135413511
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5885
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426180661
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448754251
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2067
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408762068
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22026567
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID819685
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID615637
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448080623
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23662384
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID4432
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID4432
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11579589
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503056
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID517045
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8616022
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546881
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67491
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23714925
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13870
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12761532
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447855610
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46934442
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID36654
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425553238

Total number of triples: 47.